Showing 141 - 159 results of 159 for search '"drug design"', query time: 0.06s Refine Results
  1. 141

    Discovery of orally bioavailable SARS-CoV-2 papain-like protease inhibitor as a potential treatment for COVID-19 by Yongzhi Lu, Qi Yang, Ting Ran, Guihua Zhang, Wenqi Li, Peiqi Zhou, Jielin Tang, Minxian Dai, Jinpeng Zhong, Hua Chen, Pan He, Anqi Zhou, Bao Xue, Jiayi Chen, Jiyun Zhang, Sidi Yang, Kunzhong Wu, Xinyu Wu, Miru Tang, Wei K. Zhang, Deyin Guo, Xinwen Chen, Hongming Chen, Jinsai Shang

    Published 2024-11-01
    “…Through the application of a structure-based drug design (SBDD) approach, we discover a series of novel potent non-covalent PLpro inhibitors with remarkable in vitro potency and in vivo PK properties. …”
    Get full text
    Article
  2. 142

    CADD based designing and biological evaluation of novel triazole based thiazolidinedione coumarin hybrids as antidiabetic agent by Anchal Sharma, Anmol Narang, Nitish Kumar, Rupali Rana, Megha, Pooja, Muskan Dhir, Harmandeep Kaur Gulati, Jyoti, Aanchal Khanna, Jatinder Vir Singh, Sukhraj Kaur, Preet Mohinder Singh Bedi

    Published 2025-02-01
    “…The docking scores and binding energies indicated that Compound I-1 emerged as the optimal scaffold for drug design, excluding α-amylase. Compound I-1 was synthesized based on the insights gained from molecular docking and simulations, which helped predict interactions and identify critical structural features. …”
    Get full text
    Article
  3. 143

    Evaluating the advancements in protein language models for encoding strategies in protein function prediction: a comprehensive review by Jia-Ying Chen, Jia-Ying Chen, Jia-Ying Chen, Jing-Fu Wang, Jing-Fu Wang, Jing-Fu Wang, Yue Hu, Yue Hu, Yue Hu, Xin-Hui Li, Xin-Hui Li, Xin-Hui Li, Yu-Rong Qian, Yu-Rong Qian, Yu-Rong Qian, Chao-Lin Song, Chao-Lin Song, Chao-Lin Song

    Published 2025-01-01
    “…Protein function prediction is crucial in several key areas such as bioinformatics and drug design. With the rapid progress of deep learning technology, applying protein language models has become a research focus. …”
    Get full text
    Article
  4. 144
  5. 145
  6. 146

    Economic impact of potentially inappropriate prescribing and related adverse events in older people: a cost-utility analysis using Markov models by Kathleen Bennett, Frank Moriarty, Tom Fahey, Caitriona Cahir

    Published 2019-01-01
    “…Objectives To determine the economic impact of three drugs commonly involved in potentially inappropriate prescribing (PIP) in adults aged ≥65 years, including their adverse effects (AEs): long-term use of non-steroidal anti-inflammatory drugs (NSAIDs), benzodiazepines and proton pump inhibitors (PPIs) at maximal dose; to assess cost-effectiveness of potential interventions to reduce PIP of each drug.Design Cost-utility analysis. We developed Markov models incorporating the AEs of each PIP, populated with published estimates of probabilities, health system costs (in 2014 euro) and utilities.Participants A hypothetical cohort of 65 year olds analysed over 35 1-year cycles with discounting at 5% per year.Outcome measures Incremental cost, quality-adjusted life years (QALYs) and incremental cost-effectiveness ratios with 95% credible intervals (CIs, generated in probabilistic sensitivity analysis) between each PIP and an appropriate alternative strategy. …”
    Get full text
    Article
  7. 147

    Phytocompounds from Indonesia Medicinal Herbs as Potential Apelin Receptor Agonist for Heart Failure Therapy: An In-silico Approach by Muhamad Rizqy Fadhillah, Wawaimuli Arozal, Muhammad Habiburrahman, Somasundaram Arumugam, Heri Wibowo, Suci Widya Primadhani, Aryo Tedjo, Surya Dwira, Nurul Gusti Khatimah

    Published 2025-01-01
    “…This study investigates bioactive phytochemicals from ten Indonesian medicinal herbs using computer-aided drug design (CADD) to predict ligand-receptor interactions via molecular docking and bioactivity prediction through machine learning. …”
    Get full text
    Article
  8. 148
  9. 149

    Machine learning and genetic algorithm-guided directed evolution for the development of antimicrobial peptides by Heqian Zhang, Yihan Wang, Yanran Zhu, Pengtao Huang, Qiandi Gao, Xiaojie Li, Zhaoying Chen, Yu Liu, Jiakun Jiang, Yuan Gao, Jiaquan Huang, Zhiwei Qin

    Published 2025-02-01
    “…Conclusions: The findings of this study pave the way for the rational drug design of activity-enhanced peptide antibiotics.…”
    Get full text
    Article
  10. 150

    Isolation and characterization of CNC from waste maize cob available in Bangladesh as a potential candidate for the fabrication of multifunctional bio-nanocomposites: A new approac... by Shamim Dewan, Md. Mahmudur Rahman, Md. Ismail Hossain, Bijoy Chandra Ghos, M Mohinur Rahman Rabby, Md. Abdul Gafur, Md. Al-Amin, Md. Ashraful Alam

    Published 2025-01-01
    “…., antibacterial, antifungal, anticarcinogenic activity) in wastewater treatment, drug design, food packaging, etc. CNC usually extracted from primary plant (such as jute, hemp, flax, cotton, etc.) which has other significant uses (for example preparation of yarn, rope, tissue paper, etc.). …”
    Get full text
    Article
  11. 151
  12. 152

    Chemical Synthesis, Efficacy, and Safety of Antimalarial Hybrid Drug Comprising of Sarcosine and Aniline Pharmacophores as Scaffolds by Jean Baptiste Niyibizi, Peter G. Kirira, Francis T. Kimani, Fiona Oyatsi, Joseph K. Ng’ang’a

    Published 2020-01-01
    “…Covalent bitherapy is a rational and logical way of drug design which entails joining a couple of molecules with individual intrinsic action into a unique agent, hence packaging dual activity into one hybrid. …”
    Get full text
    Article
  13. 153
  14. 154

    On Topological Indices of Fractal and Cayley Tree Type Dendrimers by Muhammad Imran, Abdul Qudair Baig, Waqas Khalid

    Published 2018-01-01
    “…These descriptors are studied and used in mathematical chemistry, medicines, and drugs designs and in other areas of applied sciences. …”
    Get full text
    Article
  15. 155

    Gliptins and Cardiovascular Outcomes: A Comparative and Critical Analysis after TECOS by Samit Ghosal, Binayak Sinha

    Published 2016-01-01
    “…This led to all the modern group of drugs designing cardiovascular safety trials (gliptins, GLP-1 agonists, and SGLT-2 inhibitors) to meet USFDA regulatory requirements. …”
    Get full text
    Article
  16. 156

    hpvPDB: An Online Proteome Reserve for Human Papillomavirus by Satish Kumar, Lingaraja Jena, Sangeeta Daf, Kanchan Mohod, Peyush Goyal, Ashok K. Varma

    Published 2013-12-01
    “…Genomic, proteomic, structural, and disease-related information on HPV is available on the web; yet, with trivial annotations and more so, it is not well customized for data analysis, host-pathogen interaction, strain-disease association, drug designing, and sequence analysis, etc. We attempted to design an online reserve with comprehensive information on HPV for the end users desiring the same. …”
    Get full text
    Article
  17. 157

    Elucidating Molecular Interactions of Natural Inhibitors with HPV-16 E6 Oncoprotein through Docking Analysis by Satish Kumar, Lingaraja Jena, Sneha Galande, Sangeeta Daf, Kanchan Mohod, Ashok K. Varma

    Published 2014-06-01
    “…A robust homology model of HPV-16 E6 was built to anticipate the interaction mechanism of E6 oncoprotein with natural inhibitory molecules using a structure-based drug designing approach. Docking analysis showed the interaction of these natural compounds with the p53-binding site of E6 protein residues 113-122 (CQKPLCPEEK) and helped the restoration of p53 functioning. …”
    Get full text
    Article
  18. 158
  19. 159

    Docking to Explicate Interface between Plant-Originated Inhibitors and E6 Oncogenic Protein of Highly Threatening Human Papillomavirus 18 by Satish Kumar, Lingaraja Jena, Maheswata Sahoo, Mrunmayi Kakde, Sangeeta Daf, Ashok K. Varma

    Published 2015-06-01
    “…E6, a high throughput protein model of HPV18, was predicted to anticipate the interaction mechanism of E6 oncoprotein with these natural inhibitors using structure-based drug designing approach. Docking analysis showed the interaction of these natural inhibitors with p53 binding site of E6 protein residues 108-117 (CQKPLNPAEK) and help reinstatement of normal p53 functioning. …”
    Get full text
    Article